Diabete: il Rosiglitazone associato a rischio di infarto miocardico ?
L’Endocrinologic and Metabolic Drugs Advisory Committee ed il Safety and Risk Management Advisory Committee dell’FDA ( Food and Drug Administration... ...
leggi